Marketplace
For Industry Partners
For Innovators
Contact sales
Sign in
Join now
TG
Thomas Geracioti
Acting CEO
RxDino, LLC
Publications
20
Funding
0
Patents
0
Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder
American Journal of Psychiatry 156 (4), 585-588, 1999
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone
Proceedings of the National Academy of Sciences 97 (1), 325-330, 2000
CSF norepinephrine concentrations in posttraumatic stress disorder
American Journal of Psychiatry 158 (8), 1227-1230, 2001
Effect of childhood physical abuse on cortisol stress response
Psychopharmacology 214, 367-375, 2011
Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression.
The American journal of psychiatry 150 (4), 656-657, 1993
Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder
Depression and anxiety 25 (3), 260-271, 2008
Corticotropin-releasing hormone in depression and post-traumatic stress disorder
Peptides 22 (5), 845-851, 2001
Impaired cholecystokinin secretion in bulimia nervosa
New England Journal of Medicine 319 (11), 683-688, 1988
Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder
Neuroimmunomodulation 9 (4), 209-217, 2002
Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression
American Journal of Psychiatry 163 (4), 637-643, 2006
Neuropeptide Y and posttraumatic stress disorder
Molecular psychiatry 18 (6), 646-655, 2013
Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder
American Journal of Psychiatry 162 (5), 992-994, 2005
Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder
Biological psychiatry 66 (7), 705-707, 2009
Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder
Psychoneuroendocrinology 33 (4), 416-424, 2008
Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression
Biological psychiatry 42 (3), 165-174, 1997
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia
Proceedings of the National Academy of Sciences 102 (23), 8303-8308, 2005
Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder
Psychoneuroendocrinology 35 (7), 1001-1007, 2010
Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans
The Journal of Clinical Endocrinology & Metabolism 74 (6), 1325-1330, 1992
Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder
Psychoneuroendocrinology 40, 277-283, 2014
Cerebrospinal fluid and plasma β-endorphin in combat veterans with post-traumatic stress disorder
Psychoneuroendocrinology 22 (7), 517-529, 1997
TG
Thomas Geracioti
Acting CEO
RxDino, LLC
Work experience
RxDino, LLC
Acting CEO
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Open to opportunities in
Medicine
Neurochemistry
Neuroendocrinology
Neuropharmacology
Last updated Feb 2025
Report Error
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
Subscribe
Company
About
Blog
Careers
Halo Awards
Support
FAQs
Help center
Feature requests
Contact support
Sponsors
Customer stories
Privacy Policy
Terms of Service
© 2026 Halo Cures, Inc.